
American Airlines CEO Robert Isom made his first appearance at the federal courthouse in Boston on Monday, testifying that American’s Northeast Alliance with JetBlue Airways was born largely out of competition with Delta.
Isom said the partnership with JetBlue would bring both airlines more routes and a bigger presence in the large New York market to stay on par with Delta. Two senior executives at Delta Air Lines urged a Boston federal judge to block a bid by American Airlines Group Inc to force them to testify in September.
Related: JetBlue CEO First Witness In DOJ Suit Against American Airlines Deal
Delta, based in Atlanta, “runs a nice airline,” Isom testified according to the Associated Press and has more takeoff and landing slots at the three major New York City airports than American. That led to the Northeast Alliance with JetBlue, which is based in New York and has a strong presence there and in Boston.
The Department of Justice and six states filed suit against American, alleging the Northeast Alliance with JetBlue amounts to a merger and violates antitrust law by creating a monopoly. With the defense testifying first since the trial began on Tuesday, September 27, witnesses so far have defended the Alliance.
The case is seen as a significant test of the Biden administration’s opposition to mergers — even though the American-JetBlue partnership is not a full merger.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Athletes File New Objections to NCAA’s $2.8 Billion Settlement Proposal
May 15, 2025 by
CPI
TikTok Charged by EU Over Alleged Breach of Digital Services Act
May 15, 2025 by
CPI
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas